Literature DB >> 30066025

[A rare manifestation of an inflammatory rheumatic systemic disease].

Ole Hudowenz1,2, Malte Knabe3, Kirsten de Groot3.   

Abstract

Granulomatosis with polyangiitis (GPA) is an ANCA(anti-neutrophil cytoplasmatic antibody)-associated small vessel vasculitis usually affecting the respiratory tract and the kidneys. This article reports on a 46-year-old male patient with a rare organ manifestation pattern of GPA: besides a fulminantly progressive tetraparesis the patient suffered from severe ulcerative colitis. The early diagnosis of GPA with unusual findings and its delineation from a septic event is essential.

Entities:  

Keywords:  Colitis; Cyclophosphamide; GPA; Polyneuropathy; Rituximab

Mesh:

Substances:

Year:  2018        PMID: 30066025     DOI: 10.1007/s00393-018-0501-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.

Authors:  Sebastian Unizony; Miguel Villarreal; Eli M Miloslavsky; Na Lu; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cg M Kallenberg; E William St Clair; David Ikle; Nadia K Tchao; Linna Ding; Paul Brunetta; Hyon K Choi; Paul A Monach; Fernando Fervenza; John H Stone; Ulrich Specks
Journal:  Ann Rheum Dis       Date:  2015-11-30       Impact factor: 19.103

Review 4.  ANCA-associated vasculitis.

Authors:  Max Yates; Richard Watts
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

5.  PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis.

Authors:  Michael Mahler; Jan Damoiseaux; Vera Ballet; Doreen Dillaerts; Chelsea Bentow; Jan-Willem Cohen Tervaert; Daniel Blockmans; Guy Boeckxstaens; Javier Aguilera-Lizarraga; Elena Csernok; Severine Vermeire; Xavier Bossuyt
Journal:  Clin Chem Lab Med       Date:  2017-11-27       Impact factor: 3.694

Review 6.  [Wegener's granulomatosis with gastrointestinal involvement].

Authors:  M D Espinosa Aguilar; M López de Hierro Ruiz; D Quintero Fuentes; F Nogueras López; M García Montero; J L Marín Aznar; M Ruiz-Cabello Jiménez; R Martín-Vivaldi Martínez
Journal:  Rev Esp Enferm Dig       Date:  1995-03       Impact factor: 2.086

7.  Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides.

Authors:  J Charles Jennette
Journal:  Clin Exp Nephrol       Date:  2013-09-27       Impact factor: 2.801

8.  The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.

Authors:  Richard A Watts; Janice Mooney; Jane Skinner; David G I Scott; Alex J Macgregor
Journal:  Rheumatology (Oxford)       Date:  2012-01-17       Impact factor: 7.580

Review 9.  Multiple ileal perforations in a patient with Wegener's granulomatosis: a case report and literature review.

Authors:  Sami Akbulut
Journal:  J Gastrointest Surg       Date:  2011-11-01       Impact factor: 3.452

10.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Authors:  M Yates; R A Watts; I M Bajema; M C Cid; B Crestani; T Hauser; B Hellmich; J U Holle; M Laudien; M A Little; R A Luqmani; A Mahr; P A Merkel; J Mills; J Mooney; M Segelmark; V Tesar; K Westman; A Vaglio; N Yalçındağ; D R Jayne; C Mukhtyar
Journal:  Ann Rheum Dis       Date:  2016-06-23       Impact factor: 27.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.